Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-254147
Filing Date
2024-11-08
Accepted
2024-11-08 16:11:32
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B5 d848172d424b5.htm 424B5 359626
2 EX-FILING FEES d848172dexfilingfees.htm   iXBRL EX-FILING FEES 23548
3 GRAPHIC g848172g01a01.jpg GRAPHIC 42812
4 GRAPHIC g848172g94j36.jpg GRAPHIC 115518
  Complete submission text file 0001193125-24-254147.txt   729074

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d848172dexfilingfees_htm.xml XML 5443
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-281194 | Film No.: 241440675
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)